Novo Nordisk A/S (OTC Pink - Current Information:NONOF)

79.57
Delayed Data
As of May 14
 +0.55 / +0.70%
Today’s Change
60.18
Today|||52-Week Range
80.70
+10.98%
Year-to-Date
Novo Nordisk, Eli Lilly Obesity Drugs Could Be Game Changers
May 13 / GuruFocus News - Paid Partner Content
These Top 2 Healthcare Companies Are In a Race to Riches
May 06 / MotleyFool.com - Paid Partner Content
Intercept (ICPT) Q1 Loss Narrower Than Expected, Sales Beat
May 07 / Zacks.com - Paid Partner Content
Novo Nordisk A/S (NVO) Q1 2021 Earnings Call Transcript
May 05 / MotleyFool.com - Paid Partner Content
PFE vs. NVO: Which Stock Should Value Investors Buy Now?
May 07 / Zacks.com - Paid Partner Content
Novo Nordisk's (NVO) Q1 Earnings and Sales Beat Estimates
May 05 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close79.02
Today’s open76.75
Day’s range76.75 - 80.70
Volume3,663
Average volume (3 months)31,023
Market cap--
Data as of 05/14/2021

Growth & Valuation

Earnings growth (last year)+12.27%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+6.13%
P/E ratio--
Price/Sales8.45
Price/Book--

Competitors

No competitors data available.

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$19.4B
Annual profit (last year)$6.4B
Net profit margin33.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Bagsværd, Capital Region

Forecasts

Chart unavailable